Z. Siddik

J. Bull, Z. Siddik, F. Strebel, 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab.

G. Mills, J. Mendelsohn, Z. Siddik, 2007, Cancer research.

Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

B. Aggarwal, Z. Siddik, S. Prasad, 2017, Front. Pharmacol..

Platinum(IV)-Ferrocene Conjugates and Their Cyclodextrin Host-Guest Complexes.

V. Lynch, J. Sessler, Z. Siddik, 2019, Inorganic chemistry.

The effects of α-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice

B. Sikic, Z. Siddik, E. Mimnaugh, 1979 .

Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.

G. Mills, R. Bast, Yiling Lu, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pharmacokinetics of liposome-entrappedcis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat

R. Perez-soler, A. Khokhar, Z. Siddik, 2004, Cancer Chemotherapy and Pharmacology.

Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21

A. Khokhar, Z. Siddik, J. Koomen, 2006, British Journal of Cancer.

Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery

R. Perez-soler, A. Khokhar, Z. Siddik, 1988, Cancer Chemotherapy and Pharmacology.

The metabolism of lysergic acid DI[14C]ethylamide ([14C]LSD) in the isolated perfused rat liver.

Z. Siddik, R. Smith, R. T. Williams, 1979, Biochemical pharmacology.

The fate of lysergic acid di[ 14C]ethlamide ([14-C-A1LSD) in the rat.

Z. Siddik, R. Smith, R. T. Williams, 1975, Biochemical Society transactions.

The fate of lysergic acid DI[14C]ethylamide ([14C]LSD) in the rat, guinea pig and rhesus monkey and of [14C]iso-LSD in rat.

Z. Siddik, R. Smith, R. T. Williams, 1979, Biochemical pharmacology.

The Fate of Lysergic Acid Di[14C]ethylamide ([14C]LSD) in the Rat

Z. Siddik, R. T. Williams, Robert L. Smith, 1975 .

A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells.

J. Sessler, Z. Siddik, J. Arambula, 2012, MedChemComm.

Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro

Z. Siddik, B. Hsi, J. Klostergaard, 1995, Cancer Chemotherapy and Pharmacology.

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.

Z. Siddik, N. Savaraj, Chunjing Wu, 2004, Molecular cancer therapeutics.

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.

I. Wistuba, S. Swisher, J. Fujimoto, 2014, Lung cancer.

Tissue platinum concentration and tumor response in non-small-cell lung cancer.

I. Wistuba, J. Lee, S. Swisher, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recruitment of trimeric proliferating cell nuclear antigen by G1-phase cyclin-dependent kinases following DNA damage with platinum-based antitumour agents

A. Khokhar, Z. Siddik, J. Koomen, 2013, British Journal of Cancer.

The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog.

A. Khokhar, Z. Siddik, J. Kuang, 2011, Gynecologic oncology.

Sex-dependent differences in the effects of portacaval anastomosis on hepatic monooxygenases in rats.

Z. Siddik, E. Mimnaugh, M. Trush, 1982, Biochemical pharmacology.

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

M. Ferrari, A. Sood, C. Ivan, 2019, EBioMedicine.

Hepatic cytochrome P-450-dependent metabolism and enzymatic conjugation of foreign compounds in vitamin A-deficient rats.

B. Sikic, Z. Siddik, E. Mimnaugh, 1980, Pharmacology.

Metabolism of new anticancer agents.

Z. Siddik, R. Newman, 1989, Pharmacology & therapeutics.

Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.

J. Bull, Z. Siddik, F. Strebel, 1991, Cancer research.

Recent developments in texaphyrin chemistry and drug discovery.

J. Cheon, Heeyeong Jeong, J. Sessler, 2013, Inorganic chemistry.

Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues.

J. Bull, J. Wondergem, Z. Siddik, 1991, Cancer research.

Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy.

Z. Siddik, S. P. Tomasovic, J. Klostergaard, 1992, Cancer research.

Lack of correlation between cortisol-induced precocious maturation of the fetal rabbit lung and drug metabolism.

B. Sikic, Z. Siddik, E. Mimnaugh, 1979, Biochemical pharmacology.

Bismuth- and lead-texaphyrin complexes: towards potential α-core emitters for radiotherapy.

V. Lynch, J. Sessler, Z. Siddik, 2010, Chemical communications.

Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1

Z. Siddik, N. Savaraj, L. Klomp, 2008, Molecular Pharmacology.

Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.

A. Khokhar, Z. Siddik, Y. Kido, 1994, Biochemical pharmacology.

Distinct P‐glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis‐diamminedichloroplatinum (II)

Z. Siddik, M. Siciliano, L. Yang, 1993, International journal of cancer.

Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells

J. Bull, L. Zwelling, Z. Siddik, 1994, Cancer Chemotherapy and Pharmacology.

Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles

C. Verschraegen, A. Khokhar, Z. Siddik, 2003, Journal of Cancer Research and Clinical Oncology.

Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide.

Z. Siddik, K. Harrap, F. Boxall, 1987, Analytical biochemistry.

Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin

A. Khokhar, Z. Siddik, G. Thai, 1994, Journal of Cancer Research and Clinical Oncology.

Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes

A. Khokhar, Z. Siddik, G. Thai, 1994, Journal of Cancer Research and Clinical Oncology.

Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes

A. Khokhar, Z. Siddik, S. Al-Baker, 2005, Journal of Cancer Research and Clinical Oncology.

Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.

A. Khokhar, Z. Siddik, J. Kuang, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.

R. Perez-soler, N. Donato, Z. Siddik, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.

Z. Siddik, D. Newell, T. Mcelwain, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.

A. Khokhar, Z. Siddik, H. Ojima, 2005, Journal of inorganic biochemistry.

Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes.

A. Khokhar, Z. Siddik, S. Al-Baker, 1993, Journal of inorganic biochemistry.

Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.

J. Bull, A. Khokhar, Z. Siddik, 1992, Cancer research.

Alterations in hepatic and renal levels of glutathione and activities of glutathione S-transferases from rats treated with cis-dichlorodiamminelatinum-II

Z. Siddik, C. Litterst, Y. Hirokata, 2004, Cancer Chemotherapy and Pharmacology.

Metabolism and biliary excretion of sulfobromophthalein in vitamin A deficiency.

Z. Siddik, R. Drew, T. E. Gram, 1980, Biochemical pharmacology.

Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate.

J. Sessler, Z. Siddik, J. Arambula, 2014, Chemistry.

Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate.

J. Sessler, Z. Siddik, J. Arambula, 2011, Bioorganic & medicinal chemistry letters.

Assessment of pulmonary and hematologic toxicities of liblomycin, a novel bleomycin analog

D. Followill, Z. Siddik, R. Newman, 1990, Investigational New Drugs.

The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.

Z. Siddik, D. Newell, K. Harrap, 1987, Biochemical pharmacology.

Synthesis, characterization, and antitumor activity of amine platinum(II) and (IV) tellurate complexes.

A. Khokhar, Z. Siddik, Q. Xu, 1994, Journal of inorganic biochemistry.

New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status

Z. Siddik, A. Isab, R. Larcher, 2016, Oncotarget.

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Anil K Sood, Robert L Coleman, Gabriel Lopez-Berestein, 2009, Clinical Cancer Research.

Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.

A. Khokhar, Z. Siddik, S. Al-Baker, 1997, Journal of medicinal chemistry.

Synthesis, characterization, and antitumor activity of 1,2-bis(diphenylphosphino) ethane platinum(II) and palladium(II) complexes.

A. Khokhar, Z. Siddik, Q. Xu, 1990, Journal of inorganic biochemistry.

Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2].

A. Khokhar, Z. Siddik, K. Whitmire, 2000, Bioorganic & medicinal chemistry.

Preparation, characterization, and antitumor activity of new cisplatin analogues with 1-methyl-4-(methylamino)piperidine: crystal structure of [PtII(1-methyl-4-(methylamino) piperidine)(oxalate)].

A. Khokhar, Z. Siddik, K. Whitmire, 2003, Journal of inorganic biochemistry.

Use of platinum as a modifier in the sensitive detection of tellurium in biological samples.

Z. Siddik, R. Newman, 1988, Analytical biochemistry.

Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2].

A. Khokhar, Z. Siddik, K. Whitmire, 1998, Journal of inorganic biochemistry.

Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group.

A. Khokhar, Z. Siddik, I. Takahashi, 1996, Journal of inorganic biochemistry.

Preparation, characterization, and antitumor activity of water-soluble aminoalkanol platinum(II) complexes.

A. Khokhar, Z. Siddik, R. Newman, 1991, Journal of inorganic biochemistry.

Cover Picture: Photoinduced Reduction of PtIV within an Anti‐Proliferative PtIV–Texaphyrin Conjugate (Chem. Eur. J. 29/2014)

J. Sessler, Z. Siddik, J. Arambula, 2014 .

Recent developments in texaphyrin chemistry and drug discovery.

J. Cheon, Heeyeong Jeong, J. Sessler, 2013, Inorganic chemistry.

Mesna does not reduce cisplatin induced nephrotoxicity in the rat

Z. Siddik, J. Millar, B. C. Millar, 1985, Cancer Chemotherapy and Pharmacology.

Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.

A. Khokhar, Z. Siddik, M. Yoshida, 1994, Anti-cancer drug design.

Preparation, characterization, and antitumor activity of new cisplatin analogs with homopiperazines: crystal structure of [PtII(1-methylhomopiperazine)(methylmalonato)].2H2O.

A. Khokhar, Z. Siddik, T. Toyomasu, 1999, Journal of inorganic biochemistry.

Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands.

A. Khokhar, Z. Siddik, Y. Kido, 1993, Journal of inorganic biochemistry.

Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.

A. Khokhar, Z. Siddik, M. Yoshida, 1994, Cancer research.

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

E Wiltshaw, A H Calvert, M. Gore, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synthesis, characterization, and antitumor activity of new chloroethylamine platinum complexes.

A. Khokhar, Z. Siddik, R. Newman, 1992, Journal of inorganic biochemistry.

Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations

Z. Siddik, N. H. Nagoor, Bavani Subramaniam, 2020, Journal of Nanoparticle Research.

Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights.

Z. Siddik, A. Farooqi, M. Djamgoz, 2019, Seminars in cancer biology.

Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.

W. Hong, R. Perez-soler, A. Khokhar, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

PHARMACOLOGICAL STUDIES WITH NEW LIPOSOME-ENTRAPPED

R. Perez-soler, A. Khokhar, Z. Siddik, 1991 .

Pharmacological Studies with New Liposome-Entrapped Cisplatin Derivatives

R. Perez-soler, A. Khokhar, Z. Siddik, 1991 .

Platelet‐derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape

Z. Siddik, A. Farooqi, Zahid H Siddik, 2015, Cell biochemistry and function.

Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tum3or cells

C. Ivan, Z. Siddik, Xiaolei Xie, 2016, Oncotarget.

Apoptosis in Cancer: Mechanisms, Deregulation, and Therapeutic Targeting

Z. Siddik, 2013 .

Drug resistance in cancer cells

Zahid H. Siddik, Z. Siddik, K. Mehta, 2009 .

Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model.

G. Mills, R. Bast, L. Pusztai, 1998, Acta oncologica.

Drug Resistance and the Tumor Suppressor p53: The Paradox of Wild-Type Genotype in Chemorefractory Cancers

Z. Siddik, 2009 .

Checkpoint controls and targets in cancer therapy

Z. Siddik, 2009 .

Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents

Z. Siddik, G. He, Xiaolei Xie, 2020, Cancer Chemotherapy and Pharmacology.

Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities

Jian Kuang, John Koomen, A. Khokhar, 2005, Oncogene.

The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.

R. Bast, M. Hung, W. Xia, 2011, Journal of the National Cancer Institute.

Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.

J. Sessler, Z. Siddik, R. McCall, 2016, Angewandte Chemie.

Targeting p21-Dependent Pathways for Cell Death in Cancer Therapy

Z. Siddik, 2010 .

Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner

Z. Siddik, T. Kurokawa, G. He, 2010, Cancer Chemotherapy and Pharmacology.

Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53.

Z. Siddik, M. Martinez-Rivera, 2012, Biochemical pharmacology.

Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.

Rajesha Rupaimoole, Anil K Sood, Hee Dong Han, 2013, Neoplasia.

Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines.

J. Sessler, Z. Siddik, D. Magda, 2009, Dalton transactions.

Pulmonary accumulation of drugs in vitamin a deficiency

Z. Siddik, M. Trush, T. E. Gram, 1979, Lung.

The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle.

J. Bull, J. Wondergem, Z. Siddik, 1988, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Correlation of total and interstrand DNA adducts in tumor and kidney with antitumor efficacies and differential nephrotoxicities of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin.

F. Ali-Osman, A. Khokhar, Z. Siddik, 1994, Biochemical pharmacology.

Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells*

G. Mills, Z. Siddik, Yibin Wang, 2003, Journal of Biological Chemistry.

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

Zhongming Zhao, A. Sood, Z. Siddik, 2020, Clinical Cancer Research.

Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill

Z. Siddik, G. He, Xiaolei Xie, 2020, Molecular Pharmacology.

ATP11B mediates platinum resistance in ovarian cancer.

P. Meltzer, M. Hendrix, Ju-Seog Lee, 2013, The Journal of clinical investigation.

ATP 11 B mediates platinum resistance in ovarian cancer

P. Meltzer, M. Hendrix, Ju-Seog Lee, 2018 .

ATP11B mediates platinum resistance in ovarian cancer.

P. Meltzer, M. Hendrix, Ju-Seog Lee, 2013, The Journal of clinical investigation.

Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy

K. Hess, I. Wistuba, J. Issa, 2015, Clinical Epigenetics.

Isolated limb perfusion with chemotherapeutic agents for melanoma: a reevaluation of drug dosimetry.

Z. Siddik, M. Edwards, A. Boddie, 1989, European journal of cancer & clinical oncology.

Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.

J. Bull, J. Wondergem, A. Khokhar, 1991, Cancer research.

Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy

Z. Siddik, D. Hohn, R. Graham, 1990, Cancer Chemotherapy and Pharmacology.

The comparative tissues distribution of platinum and 14C in mice receiving 14C-labelled carboplatin

Z. Siddik, K. Harrap, S. Dible, 1988, Cancer Chemotherapy and Pharmacology.

Comparative distribution and excretion of carboplatin and cisplatin in mice

Z. Siddik, F. Boxall, K. Harrap, 1988, Cancer Chemotherapy and Pharmacology.

Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio?

J. Bull, J. Wondergem, Z. Siddik, 1993, European journal of cancer.

Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.

J. Bull, Z. Siddik, F. Strebel, 1989, Cancer research.

Pharmacokinetics of c / s-Diammine-1 , 1-cyclobutane Dicarboxylate Platinum ( ll ) in Patients with Normal and Impaired Renal Function 1

Z. Siddik, D. Newell, S. Harland, 2006 .

Haematological toxicity of carboplatin in rats.

Z. Siddik, K. Harrap, F. Boxall, 1987, British Journal of Cancer.

Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration

S. Curley, Z. Siddik, R. Newman, 2004, Cancer Chemotherapy and Pharmacology.

A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat.

J. Bull, J. Wondergem, Z. Siddik, 1989, International journal of radiation oncology, biology, physics.

20 – Drug Resistance as a Focus for New Drug Design

Z. Siddik, P. Goddard, K. Harrap, 1988 .

Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin.

M. Gore, I. Smith, Z. Siddik, 1987, European journal of cancer & clinical oncology.

Minimising the organ toxic effects of chemotherapy.

Z. Siddik, 1986, European Journal of Cancer and Clinical Oncology.

Biliary Excretion, Renal Handling and Red Cell Uptake of Cisplatin and CBDCA in Animals

Z. Siddik, D. Newell, K. Harrap, 1984 .

Cancer Therapy: Preclinical Therapeutic Targeting of ATP7B in Ovarian Carcinoma

A. Sood, Jeong-Won Lee, Z. Siddik, 2009 .

Species and dose differences in the accumulation of imipramine by mammalian lungs.

Z. Siddik, E. Mimnaugh, E G Mimnaugh, 1981, Drug metabolism and disposition: the biological fate of chemicals.

HPLC Analysis of Cisplatin Analogues in Biological Fluids

Z. Siddik, D. Newell, K. Harrap, 1984 .

SYNTHESIS AND CHARACTERIZATION OF NEW ANTITUMOR TRANS-R,R-, TRANS-S,S- AND CIS-1,2-DIAMINOCYCLOHEXANE PLATINUM (IV) COMPLEXES

A. Khokhar, Z. Siddik, S. Al-Baker, 1994 .

Alkylating Agents and Platinum Antitumor Compounds

Z. Siddik, 2017 .

Heterozygous p53V172F mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53

G. Lozano, Z. Siddik, Xiaolei Xie, 2016, Oncogene.

Bleomycin-metal interaction: ferrous iron-initiated chemiluminescence.

Z. Siddik, E. Mimnaugh, M. Trush, 1983, Biochemical and biophysical research communications.

Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation

Z. Siddik, G. He, Xiaolei Xie, 2016, Molecular Cancer Research.

1576 – THE METABOLISM of [14C] LSD IN THE RAT

Z. Siddik, R. T. Williams, Robert L. Smith, 1977 .

Priming reduces the bone marrow toxicity of carboplatin.

M. Gore, J. Sloane, I. Smith, 1987, European journal of cancer & clinical oncology.

Kinetics of tissue disposition ofcis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSallC tumors

A. Khokhar, Z. Siddik, G. Thai, 2004, Cancer Chemotherapy and Pharmacology.

Uptake and efflux of 14C-paraquat by rat lung slices: the effect of imipramine and other drugs.

Z. Siddik, R. Drew, T. E. Gram, 1979, Toxicology and applied pharmacology.

Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).

A. Khokhar, Z. Siddik, M. Yoshida, 1994, Cancer research.

Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.

A. Khokhar, Z. Siddik, Y. Kido, 1993, Cancer research.

Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.

A. Khokhar, Z. Siddik, Y. Kido, 1993, Anti-cancer drugs.

Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.

A. Khokhar, Z. Siddik, G. Thai, 1994, Anti-cancer drug design.

Synthesis and antitumor activity of new trans-1R,2R-diaminocyclohexaneplatinum(II) complexes containing disubstituted sulfide groups

A. Khokhar, Z. Siddik, S. Al-Baker, 1996 .

Synthesis and antitumor activity of 1,2-diaminocyclohexane platinum(IV) complexes.

A. Khokhar, Z. Siddik, S. Al-Baker, 1994, Journal of inorganic biochemistry.

A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma

A. Kudelka, Z. Siddik, T. Madden, 1997, Anti-cancer drugs.

Chronic effect of whole-body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat.

J. Bull, J. Wondergem, Z. Siddik, 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents

Alan B. Watts, W. Baze, K. Hong, 2020, Proceedings of the National Academy of Sciences.

Collagen matrix cisplatin prevents local tumor growth after margin-positive resection.

F. Izzo, S. Curley, Z. Siddik, 1995, The Journal of surgical research.

Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.

J. Bull, A. Khokhar, Z. Siddik, 1993, British Journal of Cancer.

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]

A. Sood, C. Ivan, Z. Siddik, 2022, EBioMedicine.

Development and validation of a reversed-phase HPLC method for quantification of 1’-acetoxychavicol acetate content in a nanostructured lipid carrier formulation

Z. Siddik, N. H. Nagoor, Bavani Subramaniam, 2022, Brazilian Journal of Pharmaceutical Sciences.

Determination of tellurium in biological fluids by means of electrothermal vaporization-inductively coupled plasma-mass spectrometry (ETV-ICP-MS).

Z. Siddik, R. Newman, S. Osborn, 1989, Clinica chimica acta; international journal of clinical chemistry.